Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
Clinical trial NCT00805467 · TERMINATED
Trial details
- NCT number
- NCT00805467
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2013-08-01
- Enrollment
- 624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.